We are live on ! Find out more
TSC

Two Seas Capital Portfolio holdings

AUM $7.15B
1-Year Est. Return 169.27%
This Fund
S&P 500
This Quarter Est. Return
-7.86%
1 Year Est. Return
+169.27%
3 Year Est. Return
+279.82%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$10.9M
Cap. Flow
+$2.81M
Cap. Flow %
2.35%
Top 10 Hldgs %
99.55%
Holding
14
New
1
Increased
5
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
ABUS icon
Arbutus Biopharma
ABUS
+$4.2M
2
ROIV icon
Roivant Sciences
ROIV
+$3.27M
3
MTBL
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
+$2.79M
4
JOBS
51job Inc
JOBS
+$695K
5
OSG
Octave Specialty Group
OSG
+$610K

Top Sells

Rank Stock Value
1
HTZ icon
Hertz
HTZ
+$4.31M
2
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$2.3M
3
SONO icon
Sonos
SONO
+$1.3M
4
CO
Global Cord Blood Corporation
CO
+$519K
5
ENDP
Endo International plc
ENDP
+$384K

Sector Composition

Rank Sector Weight
1 Industrials 75.29%
2 Healthcare 9.2%
3 Technology 7.84%
4 Materials 4.36%
5 Financials 2.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HTZ icon
1
Hertz
HTZ
$493M
$87.4M 73.23%
3,946,291
-205,000
-5% -$4.31M
MTBL
2
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$7.06M 5.91%
3,224,710
+1,319,260
+69% +$2.79M
ABUS icon
3
Arbutus Biopharma
ABUS
$913M
$6.55M 5.49%
2,199,069
+1,373,500
+166% +$4.2M
OMEX icon
4
Odyssey Marine Exploration
OMEX
$43.5M
$5.21M 4.36%
781,818
– –
ROIV icon
5
Roivant Sciences
ROIV
$25B
$3.99M 3.34%
806,907
+495,862
+159% +$3.27M
JOBS
6
DELISTED
51job Inc
JOBS
$2.45M 2.05%
41,865
+13,564
+48% +$695K
OSG
7
Octave Specialty Group
OSG
$256M
$2.43M 2.03%
233,457
+45,000
+24% +$610K
SONO icon
8
Sonos
SONO
$1.88B
$2.3M 1.92%
81,362
-48,779
-37% -$1.3M
HTZWW
9
Hertz Global Holdings Warrants
HTZWW
$67.7M
$774K 0.65%
50,446
– –
HTZ icon
10
CALL
Hertz
HTZ
$493M
$660K 0.55%
+2,000
New +$42K
ENDP
11
DELISTED
Endo International plc
ENDP
$438K 0.37%
189,543
-130,800
-41% -$384K
ROIVW
12
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
$98K 0.08%
111,509
– –
EGRX
13
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– –
-45,099
Closed -$2.3M
CO
14
DELISTED
Global Cord Blood Corporation
CO
– –
-123,800
Closed -$519K

Similar funds

UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $7.13B AUM 35.47% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Two Seas Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Two Seas Capital held 14 positions worth $119M, down 8.4% from $130M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Two Seas Capital's Q1 2022 filing shows 1 new, 5 increased, 3 reduced and 2 closed positions. The largest sale was Hertz, an estimated $4.31M.

By sector, the portfolio is most concentrated in Industrials at 75% of assets, down from 81% a quarter earlier, followed by Healthcare and Technology.

  • Two Seas Capital added most to Arbutus Biopharma in Q1 2022, an estimated $4.2M increase.
  • Two Seas Capital's biggest Q1 2022 reduction was Hertz, cutting an estimated $4.31M.
  • Two Seas Capital fully exited Eagle Pharmaceuticals, Inc. in Q1 2022, selling an estimated $2.3M.
  • Two Seas Capital's ten largest holdings make up 100% of its $119M portfolio in Q1 2022.
  • Two Seas Capital opened 1 new position and closed 2 in Q1 2022.
  • Two Seas Capital's portfolio value fell 8.4% quarter-over-quarter to $119M.

Based on Two Seas Capital's 13F filing for Q1 2022, filed 13 May 2022.